National Vision Holdings Revenue 2015-2019 | EYE

National Vision Holdings revenue from 2015 to 2019. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
National Vision Holdings Annual Revenue
(Millions of US $)
2018 $1,537
2017 $1,375
2016 $1,196
2015 $1,063
2014 $933
National Vision Holdings Quarterly Revenue
(Millions of US $)
Q1 2019 $461
Q4 2018 $356
Q3 2018 $387
Q2 2018 $386
Q1 2018 $408
Q4 2017 $322
Q3 2017 $346
Q2 2017 $338
Q1 2017 $370
Q4 2016 $0
Q3 2016 $301
Q4 2015 $0
Q4 2014 $0
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $2.499B $1.537B
National Vision Holdings, Inc. is involved in optical retail primarily in the United States. The company offer product and services for eye care needs through retail stores and consumer websites. Its brand portfolio consists of America's Best Contacts & Eyeglasses, Eyeglass World, Vision Centers inside select Walmart stores and Vista Optical locations inside Fred Meyer stores and on select military bases. National Vision Holdings, Inc. is headquartered in Duluth, Georgia.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $149.955B 29.11
Medtronic (MDT) Ireland $133.284B 19.04
Stryker (SYK) United States $75.636B 26.99
Boston Scientific (BSX) United States $57.976B 27.79
Baxter (BAX) United States $42.043B 26.50
Zimmer Biomet Holdings (ZBH) United States $24.226B 15.56
Smith & Nephew SNATS (SNN) United Kingdom $19.156B 0.00
ResMed (RMD) United States $17.217B 32.90
Canopy Growth (CGC) Canada $13.835B 0.00
Bio-Rad Laboratories (BIO) United States $9.076B 48.12
Aurora Cannabis (ACB) Canada $7.403B 73.00
Insulet (PODD) United States $7.147B 520.74
Hill-Rom Holdings (HRC) United States $6.992B 21.20
Perrigo (PRGO) Ireland $6.052B 10.23
Haemonetics (HAE) United States $6.021B 49.14
GW Pharmaceuticals (GWPH) United Kingdom $5.237B 0.00
ICU Medical (ICUI) United States $5.130B 30.61
Hutchison China MediTech (HCM) China $3.814B 0.00
Neogen (NEOG) United States $3.238B 52.65
Agios Pharmaceuticals (AGIO) United States $2.981B 0.00
NuVasive (NUVA) United States $2.962B 24.19
Quidel (QDEL) United States $2.360B 24.49
Aphria (APHA) $1.687B 0.00
Cardiovascular Systems (CSII) United States $1.495B 858.80
Phibro Animal Health (PAHC) United States $1.220B 18.28
AtriCure (ATRC) United States $1.159B 0.00
VAREX IMAGING (VREX) United States $1.119B 23.75
Lantheus Holdings (LNTH) United States $1.081B 28.71
OrganiGram Holdings (OGI) Canada $0.993B 0.00
NanoString Technologies (NSTG) United States $0.935B 0.00
PetIQ (PETQ) United States $0.899B 21.84
Quanterix (QTRX) United States $0.846B 0.00
MacroGenics (MGNX) United States $0.812B 0.00
Omeros (OMER) United States $0.794B 0.00
Eagle Pharmaceuticals (EGRX) United States $0.771B 21.61
Cerus (CERS) United States $0.682B 0.00
TG Therapeutics (TGTX) United States $0.638B 0.00
Surmodics (SRDX) United States $0.572B 83.20
OraSure Technologies (OSUR) United States $0.552B 25.40
LeMaitre Vascular (LMAT) United States $0.545B 26.37
Meridian Bioscience (VIVO) United States $0.489B 14.95
Evolus (EOLS) United States $0.371B 0.00
Vapotherm (VAPO) United States $0.364B 0.00
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.355B 0.00
Zynex (ZYXI) United States $0.355B 36.73
BioLife Solutions (BLFS) United States $0.311B 97.41
Utah Medical Products (UTMD) United States $0.302B 20.93
Bovie Medical (APYX) United States $0.217B 0.00
Cytosorbents (CTSO) United States $0.210B 0.00
Owens & Minor (OMI) United States $0.193B 4.08
Chimerix (CMRX) United States $0.173B 0.00
Rockwell Medical (RMTI) United States $0.172B 0.00
Fonar (FONR) United States $0.140B 7.38
Female Health (VERU) United States $0.134B 0.00
BRAINSWAY LTD (BWAY) Israel $0.111B 0.00
Neurotrope (NTRP) United States $0.100B 0.00
Chembio Diagnostics (CEMI) United States $0.100B 0.00
Surface Oncology (SURF) United States $0.088B 0.00
United-Guardian (UG) United States $0.087B 19.21
Oramed Pharmaceuticals (ORMP) United States $0.062B 0.00
ImmuCell (ICCC) United States $0.049B 0.00
Senestech (SNES) United States $0.039B 0.00
Trinity Biotech (TRIB) Ireland $0.039B 13.58
Conatus Pharmaceuticals (CNAT) United States $0.031B 0.00
GUARDION HEALTH (GHSI) United States $0.030B 0.00
Cellectar Biosciences (CLRB) United States $0.021B 0.00
Valeritas Holdings (VLRX) United States $0.015B 0.00
Capricor Therapeutics (CAPR) United States $0.012B 0.00
Akers Biosciences Inc (AKER) United States $0.007B 0.00
InVivo Therapeutics Holdings (NVIV) United States $0.007B 0.00
NeuroMetrix (NURO) United States $0.005B 3.73